Drexel Institute for Biotechnology and Virology Research is a research division established in July 2004 by Drexel University College of Medicine, which shares space and resources with the Institute for Hepatitis and Virus Research (IHVR) and the Hepatitis B Foundation in Bucks County, PA, to further their mutual research goals. Drexel University College of Medicine, formerly MCP Hahnemann University, is located in Philadelphia, PA, and has the largest enrollment of any private medical school in the nation and is leader in health science education and research.
For information about how to affiliate with the Drexel Institute for Biotechnology & Virology Research, please contact with:
Hepatitis B Foundation is a 501(c)(3) nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. In 2003, the foundation established the Institute for Hepatitis and Virus Research (IHVR) to serve its research needs and to house the Hepatitis B Foundation Lab, which is dedicated solely to hepatitis B research. The Hepatitis B Foundation and the IHVR reside in the same facility, which allows a sharing of valuable resources to achieve their complementary research and outreach mission.
The mission of the Institute for Hepatitis and Virus Research is to use discovery science to find new therapies for viral hepatitis and liver cancer; to advance its research discoveries through traditional scholarship and educational opportunities; to nurture biotechnology; and to promote public health outreach programs to improve the quality of life for those affected by viral hepatitis.
Ben Franklin Technology Partners of Southeastern Pennsylvania is an independent nonprofit economic development organization, supported by the Pennsylvania Department of Community and Economic Development, to foster dynamic relationships among companies, investors, research institutions and the university community. The Institute for Hepatitis and Virus Research (IHVR) receives a grant from Ben Franklin Technology Partners to coordinate the Regional Biotechnology Council of Central Bucks and the Ben Franklin Innovations Center, which assists “start-up” biotech companies in the region.
IMMUNOTOPE is a clinical stage biotechnology company developing immunotherapy products for the treatment and prevention of cancer and chronic viral infections. Our products activate the patient’s own immune system to fight disease and prevent recurrence. Our comprehensive approach to cancer therapy focuses on the critical, unmet need to diagnose cancer at the very earliest stages and to develop effective treatments that destroy tumors and prevent metastasis. Our product portfolio includes ovarian, breast and colon cancer and hepatitis.